Associated Papers
Divergent Morphologies and Common Signaling Features of Active and Inactive Oncogenic RHOA Mutants in Yeast.
Wang C et al.
Cells, 2025
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations.
Myers CS et al.
Haematologica, 2024
Tumor-derived RHOA mutants interact with effectors in the GDP-bound state.
Lin Y et al.
Nature Communications, 2024
Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine.
Hu L et al.
Cancer Biology & Medicine, 2024
TCR Pathway Mutations in Mature T Cell Lymphomas.
Zhang Y et al.
Journal of Immunology (baltimore, Md. : 1950), 2023
Case Report: Pathogenesis With a Rare RHOA A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Cao L et al.
Frontiers in Genetics, 2022
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S et al.
Cancer Science, 2021
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
Ye Y et al.
Experimental Hematology & Oncology, 2021
RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG et al.
Critical Reviews in Biochemistry and Molecular Biology, 2020
A Rare CD4-CD8+ Adult T-Cell Leukemia/Lymphoma with Unique Molecular Mutations: A Case Report with Literature Review.
Choudhuri J et al.
Case Reports in Hematology, 2020
Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M et al.
Leukemia, 2018
Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
Fukumoto K et al.
Cancer Science, 2018
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.
Orlova A et al.
Expert Opinion on Therapeutic Targets, 2018
Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
Fujisawa M et al.
Journal of Clinical and Experimental Hematopathology : Jceh, 2017
Variegated RHOA mutations in human cancers.
Kataoka K et al.
Experimental Hematology, 2016
Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
Nagata Y et al.
Blood, 2016
[Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].
Couronné L et al.
Medecine Sciences : M/s, 2014
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T et al.
Nature Genetics, 2014